This is an explainer about esketamine, a depression treatment sold as Spravato, written for people who do not have health insurance or who plan to pay for care themselves. It covers what the treatment is, why it is expensive, what a course involves, and how people without coverage sometimes find a way in.
Most people have never heard of it
Start with some reassurance. If this treatment is new to you, you are in the majority by a wide margin. In a survey our publisher paid for, nearly three in four of 443 Midwest adults, 73 percent, had never encountered Spravato by name. Another fifth recognized it without knowing what it was. A mere 6 percent could explain it. For the 39 uninsured respondents, the blank was wider: 85 percent. Those findings are final.
Low awareness has a particular consequence for self-pay patients. When you do not know the options, you tend to meet the ones with the biggest marketing budgets first. So it helps to understand esketamine on its own terms. A plain overview of Spravato is a good place to begin.
The drug itself
Esketamine, a nasal spray made from a form of ketamine, has FDA approval in two adult groups: people whose depression resisted two or more proper antidepressant trials, and people with major depression who face acute suicidal thoughts or behavior.
Instead of the serotonin pathways most antidepressants target, it works through glutamate, one reason clinicians turn to it after standard medicines fall short.
How it is given, and why that matters for cost
Esketamine is never handed to you to take home. Under a federal safety program, it can only be used inside a certified health care setting. You spray it yourself while a clinician watches, and then you stay for at least two hours while staff monitor your blood pressure, alertness, and any side effects such as dizziness, nausea, or a sense of detachment. Driving is off until the next day, after sleep.
Each part of that adds cost. You are paying for the medication itself, which carries a high list price, plus the clinic's time, space, and staff for the observation period. Most courses open with two sessions a week for roughly a month, moves to weekly, and then continues weekly or every two weeks for as long as the clinician recommends. Multiply a session by that schedule and the total becomes significant.
We are not listing specific prices, because they vary by clinic and change over time, and a number we cannot verify would not help you. Ask any clinic for a written estimate of the full course, not a single visit.
How people without insurance sometimes get access
- Manufacturer assistance. The drug maker runs patient support and assistance programs. Eligibility rules apply and can change, so ask the treatment center or visit the manufacturer's website to see what is currently offered for people without coverage.
- Getting covered first. Many people who assume they are stuck without insurance actually qualify for Medicaid, especially in states that expanded eligibility for adults. Others can buy subsidized marketplace coverage after a qualifying life event or during open enrollment.
- Sliding-scale clinics for the first steps. Community health centers and community mental health centers charge based on income. They can diagnose depression, try standard treatments, document your history, and refer you onward.
How people weighed paying versus coverage
We gave respondents a simple tradeoff: insurance that covers the treatment but comes with extra steps, or paying yourself for a quicker, simpler start. Fifty-one percent picked coverage with the hoops. Twenty-three percent picked paying themselves. The last 26 percent were unsure. Uninsured respondents split differently: 38 percent chose the covered route.
For someone uninsured, those numbers are a reminder that you are not the only one weighing speed against cost. Nearly a quarter of the sample leaned toward the self-pay route. Just over half would rather wait for coverage. Neither choice is wrong, and it is reasonable to explore both at once: ask about assistance programs while you check your coverage eligibility.
How esketamine differs from cheaper-looking ketamine options
You may see ads for IV ketamine infusions at cash-pay clinics, or for at-home ketamine tablets delivered after a video visit. These may look more affordable on a per-visit basis. They are also meaningfully different from esketamine:
- Neither is FDA-approved for depression. Both are off-label uses of ketamine.
- At-home ketamine is taken with no one monitoring you in person, an approach the FDA has publicly warned about.
- Standards vary from provider to provider, so the questions you ask carry more weight.
Approval mattered to many of our respondents. Fifty-nine percent of respondents said FDA approval would sway their decision decisively or heavily. If approval matters to you too, confirm which product you are being offered before paying for anything.
Who decides whether it fits
Not everyone is a candidate. People with certain blood vessel conditions, a history of bleeding in the brain, or uncontrolled high blood pressure may be advised against it. Other medicines and health conditions matter too. That is why an evaluation by a clinician comes first, and why the treatment is not something to shop for like a product.
Our survey suggests most people already know this instinctively. The top answer to "whose recommendation would make you try it" was your own doctor, chosen by 74 percent. If you do not have a doctor right now, a sliding-scale clinic can become that doctor.
A short plan
- Check whether you qualify for Medicaid or subsidized marketplace coverage.
- Find a sliding-scale health center near you using findahealthcenter.hrsa.gov.
- Record each antidepressant you have taken, its dose, and its dates.
- Ask a clinician whether you should be evaluated for esketamine.
- If you are a candidate, ask the treatment center about manufacturer assistance and a written cost estimate for a full course.
If depression has reached the point where you are thinking about dying, please reach out now. A call or text to 988 connects you, free and without insurance, to the Suicide and Crisis Lifeline, whose phones never close; veterans can press 1.
Methodology
Results come from a questionnaire on Pollfish's consumer panel that 443 people between 18 and 64, in Indiana, Iowa, Kansas, Illinois, Minnesota, Missouri, Nebraska, Ohio, Oklahoma, and Wisconsin, had completed by the time it shut on June 23, 2026. The numbers are whole-sample except the uninsured breakdown, and all have passed final validation. The survey's commissioning and cost both fell to our publisher.